0001209191-23-032290.txt : 20230525
0001209191-23-032290.hdr.sgml : 20230525
20230525185457
ACCESSION NUMBER: 0001209191-23-032290
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230524
FILED AS OF DATE: 20230525
DATE AS OF CHANGE: 20230525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kozick Linda
CENTRAL INDEX KEY: 0001782274
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 23962513
MAIL ADDRESS:
STREET 1: C/O RAPT THERAPEUTICS, INC.
STREET 2: 561 ECCLES AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RAPT Therapeutics, Inc.
CENTRAL INDEX KEY: 0001673772
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473313701
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 489-9000
MAIL ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLX Bio, Inc.
DATE OF NAME CHANGE: 20160504
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-24
0
0001673772
RAPT Therapeutics, Inc.
RAPT
0001782274
Kozick Linda
C/O RAPT THERAPEUTICS, INC.
561 ECCLES AVENUE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
0
Stock Option (right to buy)
20.93
2023-05-24
4
A
0
12940
0.00
A
2033-05-23
Common Stock
12940
12940
D
The Option shall vest on the earlier of (i) May 24, 2024, or (ii) one day prior to the date of the Issuer's next annual meeting of stockholders to be held in 2024, subject to the Reporting Person's continuous service through each applicable vesting date.
/s/ Rodney Young, Attorney-in-Fact for Linda Kozick
2023-05-25